Efizonerimod alfa is a potent monoclonal antibody OX40 activator. Efizonerimod alfa can be used for cancer research.
References:
[1]. Valter Longo, et al. Reduced caloric intake and immunotherapy for the treatment of cancer. WO2021198439A1.
















